AstraZeneca commits $35m to help young people tackle the threat of non-communicable diseases
Young Health Programme to run to 2025 with extension of funding commitmentAstraZeneca will extend funding for its award-winning Young Health Programme for a further five years with a pledge of $35m (£28m) to help to educate young people on the steps they can take to reduce the risk of non-communicable diseases. These diseases, which include cancer, diabetes, heart disease and heart failure, are responsible for the majority of deaths worldwide, and over two-thirds of those deaths can be directly attributed to behaviour that begins in adolescence.[1,2] The Young Health Programme was